(816) 674-4100

CORNERING THE MARKET ON CANCER

There is a fascinating article in a recently published, special edition of Forbes detailing efforts by Novartis to become the leading force in cancer therapeutics. The article begins with a powerful and poignant story in which a breakthrough therapy brings a new lease...

A Case Study in Greed

“Health is Priceless:” A recent article in the New York Times stated that pharmaceutical companies are employing a new rationale to justify the seemingly irrationally, exorbitant prices being charged for pharmaceuticals: “Health is priceless.” While true,...